Form 8.3 - Horizon Therapeutics plc

Contacts

Contacts

Contacts

Search

May 22, 2023 10:25 AM Eastern Daylight Time

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	19^th May 2023

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,786,804 (2.092%)		800 (0.000%)
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	558,700 (0.244%)		1,548,600 (0.677%)
Total	5,345,504 (2.337%)		1,549,400 (0.677%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Ap20

1. DEALINGS (Note 4)

a. Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Sale	172	101.44
Sale	160	101.59
Sale	200	101.65
Sale	100	101.69
Sale	17	101.58
Sale	69	101.57
Sale	154	101.54
Sale	139	100.75
Sale	200	101.56
Sale	200	101.48
Sale	100	101.07
Sale	100	101.05
Sale	12	101.04
Sale	200	100.97
Sale	1,192	100.89
Sale	187	100.87
Sale	894	101.15
Sale	100	100.60
Sale	200	100.83
Sale	542	101.45
Sale	101	101.65
Sale	300	101.57
Sale	20	100.49
Sale	100	100.44
Sale	2	100.82
Sale	15	100.63
Sale	15	101.53
Sale	100	101.52
Sale	1,065	100.96
Sale	16	100.80
Sale	301	101.54
Sale	20	100.41
Sale	300	101.63
Sale	200	101.68
Sale	157	100.75
Sale	5	100.72
Sale	20	100.48
Sale	5	100.79
Sale	1	100.81
Sale	300	100.77
Sale	2,734	101.41
Sale	384	100.90
Sale	100	101.77
Sale	100	101.40
Purchase	100	100.84
Purchase	100	100.87
Sale	1,038	101.45
Purchase	300	100.85
Purchase	500	100.80
Purchase	726	100.75
Purchase	300	101.56
Sale	10	101.56
Sale	1,374	101.29
Sale	1,794	101.30
Sale	310	101.13
Sale	623	101.03
Purchase	100	101.10
Sale	37	101.10
Sale	400	101.35
Sale	18	101.27
Purchase	100	101.48
Sale	12,153	101.48
Sale	560	101.39
Purchase	100	101.61
Sale	340	101.59
Sale	244	101.14
Sale	538	101.12
Sale	916	101.31
Sale	7,021	101.00
Sale	2,832	101.08
Sale	321	101.07
Sale	327	101.19
Sale	318	101.16
Sale	1,541	101.05
Sale	2,191	101.32
Purchase	1,000	101.24
Sale	117	101.24
Sale	1,896	101.04
Sale	497	101.18
Purchase	1,927	101.11
Sale	2,611	101.11
Sale	816	101.01
Purchase	2,590	101.06
Sale	1,556	101.06
Sale	272	101.22
Sale	335	100.97
Sale	21	100.91
Sale	180	100.88
Purchase	383	101.09
Sale	2,115	101.09
Sale	1,197	100.89
Sale	166	100.84
Sale	9	100.95
Sale	536	100.87
Sale	139	100.93
Sale	1,389	101.25
Sale	200	100.59
Sale	500	100.86
Sale	456	101.15
Purchase	605	100.74
Sale	48	100.74
Sale	559	100.83
Sale	856	101.33
Purchase	320	101.45
Purchase	1,200	101.65
Sale	144	101.65
Purchase	8,800	101.66
Purchase	300	101.69
Purchase	898	101.58
Sale	1	100.57
Sale	18	100.71
Sale	11	101.60
Purchase	15	101.96
Purchase	714	101.91
Sale	1,198	101.26
Purchase	919	101.57
Sale	700	101.57
Sale	120	100.85
Sale	3,700	100.69
Purchase	2,000	101.67
Sale	306	101.21
Sale	103	100.35
Sale	1,058	101.38
Sale	14	100.44
Sale	2	100.42
Sale	200	100.39
Sale	3,190	100.82
Sale	4	100.43
Purchase	731	101.50
Sale	100	101.50
Purchase	3,000	100.40
Sale	138	100.40
Sale	1	100.63
Sale	130	100.78
Sale	364	101.52
Sale	3,377	101.34
Sale	1,300	100.70
Purchase	1,065	100.96
Sale	146	100.96
Purchase	200	101.54
Sale	234	101.54
Sale	269	100.65
Sale	857	101.36
Sale	1	100.41
Sale	100	101.63
Purchase	500	101.73
Purchase	345	101.76
Purchase	2,048	101.55
Purchase	2	101.68
Purchase	2,597	101.28
Sale	1,005	101.28
Purchase	700	101.51
Sale	811	101.51
Sale	337	101.02
Purchase	300	101.72
Purchase	335	101.49
Sale	961	101.46
Sale	2,360	101.20
Purchase	2,595	100.75
Sale	92	100.75
Sale	120	100.48
Purchase	100	100.73
Sale	250	100.73
Sale	400	100.79
Sale	2,250	101.37
Sale	1,310	100.77
Sale	5,860	101.42
Sale	1,150	100.90
Purchase	12,403	101.47
Sale	200	101.86
Purchase	350	101.70
Sale	6	101.62
Sale	100	100.66
Sale	4	100.37

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Put Option

Purchasing

2,300

100.00

American

6/16/2023

ii. Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)
Call Option	25,000	100.00 USD
Put Option	50,200	110.00 USD
Call Option	25,000	95.00 USD
Put Option	10,000	105.00 USD
Put Option	800	110.00 USD
Put Option	4,400	110.00 USD
Put Option	40,600	110.00 USD

d. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	22^nd May 2023
Contact name	Stephen Glasper
Telephone number	+44 203 398 2166
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	201,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	29,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	3,600	105.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	10,900	105.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Written	99,500	115.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300,000	85.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	269,300	100.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	53,500	95.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	250,000	70.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	250,000	85.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	50,000	90.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	50,000	90.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Purchased	50,000	100.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	80,000	101.00	American	5/26/2023
IE00BQPVQZ61	Call Option	Purchased	125,300	110.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	150,000	100.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Written	80,000	105.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	1,500	110.00	American	17/11/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1101200

Time of Receipt (offset from UTC): 20230522T142028+0100

Millennium Partners, L.P.

Class of relevant security:

Number

Number

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell